Suchergebnisse - "Madhav Dhodapkar"

1

A survey-wide association study to identify youth-specific correlates of major depressive episodes.

von: Rahul Madhav Dhodapkar

2020, in: PLoS ONE

Wird geladen...
2

Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma

von: Yanyan Gu

2020, in: Blood Cancer Journal

Wird geladen...
3

2168

von: Andrew Branagan

2017, in: Journal of Clinical and Translational Science

Wird geladen...
4

403 Correlative analysis of blood and biopsy samples from a clinical trial of Hsp90 inhibition in combination with pembrolizumab reveals increased intratumoral myeloid cell accumulation after treatment

von: Mohammad Zaidi

2021, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
5

330 Investigating the clinical safety, efficacy, and immune modulation of combined XL888 and pembrolizumab in metastatic gastrointestinal malignancies

von: Mohammad Zaidi

2020, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
6

P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C

von: Melissa Alsina

2023, in: HemaSphere

Wird geladen...
7

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma

von: Yi Lin

2020, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
8

S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

von: Hans C. Lee

2023, in: HemaSphere

Wird geladen...
9

Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)

von: James L Gulley

2022, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
10

Challenges and next steps in the advancement of immunotherapy: summary of the 2018 and 2020 National Cancer Institute workshops on cell-based immunotherapy for solid tumors

von: Nirali Shah

2021, in: Journal for ImmunoTherapy of Cancer

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!